Gene expression property of high-density three-dimensional tissue of HepG2 cells formed in radial-flow bioreactor

Journal of Bioscience and Bioengineering

Volumn 101, Issue 3, 2006, Pages 243-250

  Hongo, Tomokatsu ^a,c   Kajikawa, Mariko ^a   Ishida, Seiichi ^b   Ozawa, Shogo ^b   Ohno, Yasuo ^b   Sawada, Jun Ichi ^b   Ishikawa, Yoichi ^a   Honda, Hiroyuki ^c  

^a Able Co Ltd   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

DNA microarray; radial flow bioreactor; three dimensional high density cell culture

Indexed keywords

BIOMARKERS; BIOREACTORS; BLOOD VESSELS; CELL CULTURE; CELLS; DNA; GENES; GROWTH KINETICS; MATHEMATICAL MODELS; PROTEINS; TUMORS;

CELL CYCLE; DNA MICROARRAY; RADIAL-FLOW BIOREACTOR; THREE-DIMENSIONAL HIGH-DENSITY CELL CULTURE; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

GENETIC ENGINEERING;

DISSOLVED OXYGEN; TUMOR MARKER; VASCULOTROPIN; OXYGEN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; BIOREACTOR; BLOOD VESSEL; CELL CYCLE ARREST; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIVER CELL; MODEL; PHENOTYPE; STATISTICAL SIGNIFICANCE; TISSUE CULTURE; TISSUE CULTURE CELL; TISSUE CULTURE TECHNIQUE; TUMOR GROWTH; UMBILICAL VEIN; ANOXIA; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

ANOXIA; BIOREACTORS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXYGEN; TUMOR MARKERS, BIOLOGICAL; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745713595     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.101.243     Document Type: Article

References (47)

1. Kawada M., Nagamori S., Aizaki H., Fukaya K., Niiya M., Matsuura T., Sujino H., Hasumura S., Yoshida H., Mizutani S., and Ikenaga H. Massive culture of human liver cancel cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines. In Vitro Cell Dev. Biol. Anim. 34 (1998) 109-115
2. Iwahori T., Matsuura T., Maehashi H., Sugo K., Saito M., Hosokawa M., Chiba K., Masaki T., Aizaki H., Ohkawa K., and Suzuki T. CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Hepatology 37 (2003) 665-673
3. Aizaki H., Nagamori S., Matsuda M., Kawakami H., Hashimoto O., Ishiko H., Kawada M., Matsuura T., Hasumura S., Matsuura Y., Suzuki T., and Miyamura T. Production and release of infectious hepatitis C virus from human liver cell culture in the three-dimensional radial-flow bioreactor. Virology 314 (2003) 16-25
4. Sakai Y., Furukawa K., and Suzuki M. Immobilisation and long-term albumin secretion of hepatocyte spheroids rapidly formed by rotation tissue culture methods. Biotechnol. Tech. 6 (1992) 527-532
5. Kurosawa H., Yuminamochi E., Yasuda R., and Amano Y. Morphology and albumin secretion of adalt rat hepatocytes cultured on a hydrophobic porous expanded polytetrafluoroethylene membrane. J. Biosci. Bioeng. 95 (2003) 59-64
6. Yamada K., Kamihira M., and Iijima S. Enhanced cell aggregation and liver functions using polymers modified with a cell-specific ligand in primary hepatocyte cultures. J. Biosci. Bioeng. 88 (1999) 557-562
7. Khaoustov V.I., Risin D., Pellis N.R., and Yoffe B. Microarray analysis of genes differentiatially expression in HepG2 cell cultured in simulated microgravity: preliminary report. In Vitro Cell Dev. Biol. Anim. 37 (2001) 84-88
8. Hongo T., Kajikawa M., Ishida S., Ozawa S., Ohno Y., Sawada J., Umezawa A., Ishikawa Y., Kobayashi T., and Honda H. Three-dimensional high-density culture of HepG2 cells in a 5-ml radial-flow bioreactor for construction of artificial liver. J. Biosci. Bioeng. 99 (2005) 237-244
9. Aguiree Ghiso J.A., Kovalski K., and Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J. Cell Biol. 147 (1999) 89-104
10. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
11. Mazure N.M., Chen E.Y., Laderoute K.R., and Giaccia A.J. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90 (1997) 3322-3331
12. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., Bachmann M.H., Borowsky A.D., Ruebner B., Cardiff R.D., Yang Q., Bishop J.M., Contag C.H., and Felsher D.W. MYC inactivation uncovers pluripotent differentiation and tumor dormancy in hepatocellular cancer. Nature 431 (2004) 1112-1117
13. Hanafusa T., Yumoto Y., Nouso K., Nakatsukasa H., Onishi T., Fujikawa T., Taniyama M., Nakamura S., Uemura M., Takuma Y., Yumoto E., Higashi T., and Tsuji T. Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett. 176 (2002) 149-158
14. Claffey K.P., and Robinson G.S. Regulation of VEGF/VPE expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev. 15 (1996) 165-176
15. Ferrara N., and Alitalo K. Clinical application of angiogenic growth factors and their inhibitors. Nat. Med. 5 (1999) 1359-1364
16. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., and Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362 (1993) 841-844
17. Millauer B., Shawver L.K., Plate K.H., Risau W., and Ullrich A. Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant. Nature 367 (1994) 576-579
18. Saleh M., Stacker S.A., and Wilks A.F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res. 56 (1996) 393-401
19. Okino K., Konishi H., Doi D., Yoneyama K., Ota Y., Jin E., Kawanami O., and Takeshita T. Up-regulation of growth factor receptor-bound protein 10 in cervical sequamous cell carcinoma. Oncol. Rep. 13 (2005) 1069-1074
20. Suganuma T., Ito K., Shibata K., Kajiyama H., Nagasaka T., Mizutani S., and Kikkawa F. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin. Cancer Res. 11 (2005) 2686-2694
21. Saarnio J., Parkkila S., Parkkila A.K., Pastorekova S., Haukipuro K., Pastorek J., Juvenen T., and Kartunen A.J. Transmembrane carbonic anhydrase, MN/CA IX, is a potential biomaker for biliary tumor. J. Hepatol. 35 (2001) 643-649
22. Baer S., Casaubon L., Schwartz M.R., Marcogliese A., and Younes M. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival. Laryngoscope 112 (2002) 393-396
23. Oehler M.K., Fischer D.C., Orlowska-Volk M., Herrle F., Kieback D.G., Rees M.C., and Bicknell R. Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. Br. J. Cancer 89 (2003) 1927-1933
24. Chakrabarti L., Turley H., Campo L., Han C., Harris A.L., Gatter K.C., and Fox S.B. The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumor grade in human breast cancers. Br. J. Cancer 91 (2004) 954-958
25. Tang Z.Y., Sun F.X., Tian J., Ye S.L., Liu Y.K., Liu K.D., Xue Q., Chen J., Xia J.L., Qin L.X., and other 9 authors. Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential. World J. Gastroenterol. 7 (2001) 597-601
26. Huynh H., Chow P.K., Ooi L.L., and Soo K.C. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Cell Growth Differ. 13 (2002) 115-122
27. Lin X., Nelson P., and Gelman I.H. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)→S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol. Cell Biol. 20 (2000) 7259-7272
28. Sone H., Kawakami Y., Okuda Y., Kondo S., Hanatani M., Suzuki H., and Yamashita K. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine pigmented epithelial cells. Biochem. Biophys. Res. Commun. 221 (1996) 193-198
29. Hermes M., Osswald H., Mattar J., and Kloor D. Influence of an alter methylation potential on mRNA methylation and gene expression in HepG2 cells. Exp. Cell Res. 294 (2004) 325-334
30. Hasebe Y., Egawa K., Yamazaki Y., Kunimoto S., Hirai Y., Ide Y., and Nose K. Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids. Biol. Pharm. Bull. 26 (2003) 1379-1383
31. Jensen R.L. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg. Neurol. 49 (1998) 189-195
32. Mizukami Y., Jo W.S., Duerr E.M., Gala M., Li J., Zhang X., Zimmer M.A., Iliopoulos O., Zukerberg L.R., Kohgo Y., Lynch M.P., Rueda B.R., and Chung D.C. Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-dificient colon cancer cells. Nat. Med. 11 (2005) 992-997
33. Payet L.D., Wang X.H., Baxter R.C., and Firth S.M. Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperated to bind IGFs with high affinity and inhibit IGF receptor interactions. Endcrinology 144 (2003) 2797-2806
34. Dufresne A.M., and Smith R.J. The adaptor protein GRB10 is an endogeneous negative regulator of insulin-like growth factor signaling. Endocrinology 146 (2005) 4399-4409
35. Shiura H., Miyoshi N., Konishi A., Wakisaka-Saito N., Suzuki R., Muguruma K., Kohda T., Wakana S., Yokoyama M., Ishino F., and Kaneko-Ishino T. Meg1/Grb10 overexpression causes postnatal growth retardation and insulin resistance via negative modulation of the IGF1R and IR cascade. Biochem. Biophys. Res. Commun. 329 (2005) 909-916
36. Zeng H., Dvorak H.F., and Mukhopodyay D. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phophatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 276 (2001) 26969-26979
37. Wenger R.H., Rolfs A., Marti H.H., Bauer C., and Gassmann M. Hypoxia, a novel inducer of acute phase gene expression in human hepatoma cell line. J. Biol. Chem. 270 (1995) 27865-27870
38. 2+ and protein kinase C signaling pathway in HepG2 human hepatoblastoma cells. Int. J. Mol. Med. 7 (2001) 91-96
39. Ren Y., Cao B., Law S., Xie Y., Lee P.Y., Cheung L., Chen Y., Huang X., Chan H.M., Zhao P., Luk J., Vande Woude G., and Wong J. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin. Cancer Res. 11 (2005) 6170-6197
40. Mueller M.D., Vigne J.L., Minchenko A., Lebovic D.I., Leitman D.C., and Taylor R.N. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc. Natl. Acad. Sci. USA 97 (2000) 10972-10977
41. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15 (1999) 551-578
42. Semenza G.L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88 (2000) 1474-1480
43. Herve M.A., Buteau-Lozano H., Mourah S., Calvo F., and Perrot-Applanat M. VEGF189 stimulates endpthelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA. Exp. Cell Res. 309 (2005) 24-31
44. Suzuki H., Seto K., Shinoda Y., Mori M., Ishimura Y., Suematsu M., and Ishii H. Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed Hep G2 cells. Am. J. Physiol. 276 (1999) G92-G97
45. Sonna L.A., Cullivan M.L., Sheldon H.K., Pratt R.E., and Lilly C.M. Effect of hypoxia on gene expression by human hepatocytes (HepG2). Physiol. Genomics 12 (2003) 195-207
46. Bobrovnikova-Marjon E.V., Marjon P.L., Barbash O., Vander Jagt D.L., and Abcouwer S.F. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Cancer Res. 64 (2004) 4858-4869
47. Baldwin Jr. A.S. The NF-kappaB and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683